Irritable bowel syndrome (IBS) is a chronic and debilitating functional gastrointestinal
disorder that affects 9%-23% of the population across the world. The percentage of patients …

Irritable bowel syndrome (IBS) is a common medical condition characterized by chronic,
recurrent, abdominal pain and discomfort, and altered bowel habits that occur in the …

What is known and Objective: The complexity and diversity of irritable bowel syndrome's
(IBS) presentation make treatment difficult. Although there are reviews and guidelines for …

The understanding of irritable bowel syndrome (IBS) has undergone a rapid evolution with
scientific advancement. IBS is a common functional bowel disorder that generates a …

Irritable bowel syndrome (IBS), a chronic gastrointestinal disorder, affects from 3–20% of the
US population, depending on sociocultural and comorbid factors. IBS is characterized by a …

Importance Irritable bowel syndrome (IBS) affects 7% to 21% of the general population. It is
a chronic condition that can substantially reduce quality of life and work productivity …

Based on clinical studies, the Rome Criteria for the irritable bowel syndrome (IBS) were
developed by consensus. The criteria emphasize the presence of abdominal pain and the …

Irritable bowel syndrome (IBS) remains a clinical challenge in the 21 st century. It's the most
commonly diagnosed gastrointestinal condition and also the most common reason for …

Irritable bowel syndrome (IBS) is the most prevalent of the functional gastrointestinal
disorders (FGIDs). Current estimates are that IBS affects up to 10–12% of adults in North …

Irritable bowel syndrome (IBS) is one of the most common gastrointestinal disorders,
characterized by abdominal pain, bloating, and changes in bowel habits. These symptoms …